Synergistic tumor suppression by adenovirus-mediated inhibitor of growth 4 and interleukin-24 gene cotransfer in hepatocarcinoma cells

Cancer Biotherapy and Radiopharmaceuticals

Volumn 26, Issue 6, 2011, Pages 681-695

  Xie, Yufeng ^a,b   Lv, Haitao ^c   Sheng, Weihua ^a   Miao, Jingcheng ^a   Xiang, Jim ^b   Yang, Jicheng ^a  

^a SOOCHOW UNIVERSITY   (China)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c CHILDREN S HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

adenoviral vector; hepatocarcinoma; IL 24; ING4; synergistic antitumor activity

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; CD34 ANTIBODY; CYTOCHROME C; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FAS LIGAND; GELATINASE A; GELATINASE B; INHIBITOR OF GROWTH 4 PROTEIN; INTERLEUKIN 24; INTERLEUKIN 8; PROTEIN BAD; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN BID; PROTEIN P21; PROTEIN P27; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADENOVIRUS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GENE THERAPY; CANCER INHIBITION; CARCINOMA CELL; CELL STRAIN HEPG2; FEMALE; GENE TRANSFER; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR XENOGRAFT;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE PROTEINS; CELL LINE, TRANSFORMED; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TRANSFER TECHNIQUES; HEK293 CELLS; HOMEODOMAIN PROTEINS; HUMANS; INTERLEUKIN-8; INTERLEUKINS; LIVER NEOPLASMS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; TUMOR SUPPRESSOR PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 83455262917     PISSN: 10849785     EISSN: 15578852     Source Type: Journal    
DOI: 10.1089/cbr.2011.1047     Document Type: Article

References (45)

1. He GH, Helbing CC, Wagner MJ, et al. Phylogenetic analysis of the ING family of PHD finger proteins. Mol Biol Evol 2005;22:104.
2. Aasland R, Gibson TJ, Stewart AF. The PHD finger: Implications for chromatin-mediated transcriptional regulation. Trends Biochem Sci 1995;20:56.
3. Doyon Y, Cayrou C, Ullah M, et al. ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation. Mol Cell 2006;21:51.
4. Kim S, Chin K, Gray JW, et al. A screen for genes that suppress loss of contact inhibition: Identification of ING4 as a candidate tumor suppressor gene in human cancer. Proc Natl Acad Sci USA 2004;101:16251.
5. Gunduz M, Nagatsuka H, Demircan K, et al. Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas. Gene 2005;356:109.
6. Garkavtsev I, Kozin SV, Chernova O, et al. The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis. Nature 2004;428:328.
7. Fang F, Luo LB, Tao YM, et al. Decreased expression of inhibitor of growth 4 correlated with poor prognosis of he-patocellular carcinoma. Cancer Epidemiol Biomarkers Prev 2009;18:409.
8. Li J, Martinka M, Li G. Role of ING4 in human melanoma cell migration, invasion and patient survival. Carcinogenesis 2008;29:1373.
9. Li M, Jin Y, Sun WJ, et al. Reduced expression and novel splice variants of ING4 in human gastric adenocarcinoma. J Pathol 2009;219:87.
10. Shiseki M, Nagashima M, Pedeux RM, et al. p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity. Cancer Res 2003;63:2373.
11. Zhang X, Xu LS, Wang ZQ, et al. ING4 induces G2/M cell cycle arrest and enhances the chemosensitivity to DNA-damage agents in HepG2 cells. FEBS Lett 2004;570:7.
12. Xie Y, Zhang H, Sheng W, et al. Adenovirus-mediated ING4 expression suppresses lung carcinoma cell growth via induction of cell cycle alteration and apoptosis and inhibition of tumor invasion and angiogenesis. Cancer Lett 2008; 271:105.
13. Cai L, Li X, Zheng S, et al. Inhibitor of growth 4 is involved in melanomagenesis and induces growth suppression and apoptosis in melanoma cell line M14. Melanoma Res 2009;19:1.
14. Xie YF, Sheng W, Xiang J, et al. Adenovirus-mediated ING4 expression suppresses pancreatic carcinoma cell growth via induction of cell-cycle alteration, apoptosis, and inhibition of tumor angiogenesis. Cancer Biother Radiopharm 2009;24:261.
15. Colla S, Tagliaferri S, Morandi F, et al. The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 alpha (HIF-1alpha) activity: Involvement in myeloma-induced angiogenesis. Blood 2007;110:4464.
16. Shen JC, Unoki M, Ythier D, et al. Inhibitor of growth 4 suppresses cell spreading and cell migration by interacting with a novel binding partner, liprin alpha1. Cancer Res 2007;67:2552.
17. Jiang H, Lin JJ, Su ZZ, et al. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene 1995;11:2477.
18. Sauane M, Gopalkrishnan RV, Sarkar D, et al. MDA-7/IL-24: Novel cancer growth suppressing and apoptosis inducing cytokine. Cytokine Growth Factor Rev 2003;14:35.
19. Fisher PB. Is mda-7/IL-24 a "magic bullet" for cancer. Cancer Res 2005;65:10128.
20. Saeki T, Mhashilkar A, Swanson X, et al. Inhibition of human lung cancer growth following adenovirus-mediated mda-7 gene expression in vivo. Oncogene 2002;21:4558.
21. Ramesh R, Mhashilkar AM, Tanaka F, et al. Melanoma differentiation- associated gene 7/interleukin (IL)-24 is a novel ligand that regulates angiogenesis via the IL-22 receptor. Cancer Res 2003;63:5105.
22. Nishikawa T, Ramesh R, Munshi A, et al. Adenovirus-mediated mda-7 (IL24) gene therapy suppresses angiogen-esis and sensitizes NSCLC xenograft tumors to radiation. Mol Ther 2004;9:818.
23. Inoue S, Branch CD, Gallick GE, et al. Inhibition of Src ki-nase activity by Ad-mda7 suppresses vascular endothelial growth factor expression in prostate carcinoma cells. Mol Ther 2005;12:707.
24. Caudell EG, Mumm JB, Poindexter N, et al. The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated IL-24. J Immunol 2002;168:6041.
25. Ramesh R, Ito I, Gopalan B, et al. Ectopic production of MDA-7/IL-24 inhibits invasion and migration of human lung cancer cells. Mol Ther 2004;9:510.
26. Park MA, Yacoub A, Sarkar D, et al. PERK-dependent regulation of MDA-7/IL-24-induced autophagy in primary human glioma cells. Autophagy 2008;4:513.
27. Yacoub A, Hamed HA, Allegood J, et al. PERK-dependent regulation of ceramide synthase 6 and thioredoxin play a key role in mda-7/IL-24-induced killing of primary human glioblastoma multiforme cells. Cancer Res 2010;70:1120.
28. Parkin DM, Bray F, Ferlay J, et al. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;94:153.
29. Pang R, Poon RT. Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma. Cancer Lett 2006;242:151.
30. Wilson DR. Viral-mediated gene transfer for cancer treatment. Curr Pharm Biotechnol 2002;3:151.
31. He TC, Zhou S, da Costa LT, et al. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998;95:2509.
32. Ngoi SM, Chien AC, Lee CG. Exploiting internal ribosome entry sites in gene therapy vector design. Curr Gene Ther 2004;4:15.
33. Yu X, Zhan X, D'Costa J, et al. Lentiviral vectors with two independent internal promoters transfer high-level expression of multiple transgenes to human hematopoietic stem-progenitor cells. Mol Ther 2003;7:827.
34. Weidner N. Current pathologic methods for measuring in-tratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat 1995;36:169.
35. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402.
36. Wang W, Qin SK, Chen BA, et al. Experimental study on antitumor effect of arsenic trioxide in combination with cisplatin or doxorubicin on hepatocellular carcinoma. World J Gastroenterol 2001;7:702.
37. Lebedeva IV, Emdad L, Su ZZ, et al. mda-7/IL-24, novel anticancer cytokine: Focus on bystander antitumor, radio-sensitization and antiangiogenic properties and overview of the phase I clinical experience (Review). Int J Oncol 2007; 31:985.
38. Vousden KH, Prives C. Blinded by the light: The growing complexity of p53. Cell 2009;137:413.
39. Danial NN, Korsmeyer SJ. Cell death: Critical control points. Cell 2004;116:205.
40. Dvorak HF. Vascular permeability factor/vascular endo-thelial growth factor: A critical cytokine in tumor angio-genesis and a potential target for diagnosis and therapy. J Clin Oncol 2002;20:4368.
41. Belperio JA, Keane MP, Arenberg DA, et al. CXC chemo-kines in angiogenesis. J Leukoc Biol 2000;68:1.
42. Brat DJ, Bellail AC, Van Meir EG. The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro Oncol 2005;7:122.
43. Egeblad M, Werb Z. New functions for the matrix metallo-proteinases in cancer progression. Nat Rev Cancer 2002; 2:161.
44. Schmalfeldt B, Prechtel D, Harting K, et al. Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer. Clin Cancer Res 2001;7:2396.
45. Klein G, Vellenga E, Fraaije MW, et al. The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g., acute leukemia. Crit Rev Oncol Hematol 2004;50:87.